<SEC-DOCUMENT>0000784199-23-000092.txt : 20230519
<SEC-HEADER>0000784199-23-000092.hdr.sgml : 20230519
<ACCEPTANCE-DATETIME>20230519122655
ACCESSION NUMBER:		0000784199-23-000092
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230519
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230519
DATE AS OF CHANGE:		20230519

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARTIVION, INC.
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		23938984

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOLIFE INC
		DATE OF NAME CHANGE:	19940526
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aort-20230519.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:dbb8ef44-ff75-4ea4-a34d-496f46f68ada,g:82f8bde6-0e78-4319-9a8d-c7fab6609d31,d:8b931c37fabd429398de685ab45b2d69--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>aort-20230519</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV80L2ZyYWc6MWVmZDUwOTdhZGU5NGZmMWFlNzYyZjQ1ZGQzZmY0YjcvdGFibGU6OTdhOWRiNDVjOTIxNDQ3ZGFjZmM0MzUxYWEwMjZlYjkvdGFibGVyYW5nZTo5N2E5ZGI0NWM5MjE0NDdkYWNmYzQzNTFhYTAyNmViOV8wLTEtMS0xLTY1NzQy_e0449943-ceb3-4b22-9cfe-a20e07a4b3ef">0000784199</ix:nonNumeric><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV80L2ZyYWc6MWVmZDUwOTdhZGU5NGZmMWFlNzYyZjQ1ZGQzZmY0YjcvdGFibGU6OTdhOWRiNDVjOTIxNDQ3ZGFjZmM0MzUxYWEwMjZlYjkvdGFibGVyYW5nZTo5N2E5ZGI0NWM5MjE0NDdkYWNmYzQzNTFhYTAyNmViOV8xLTEtMS0xLTY1NzQy_b8be5793-6eea-4bd4-834e-840efff147d9">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="aort-20230519.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-19</xbrli:startDate><xbrli:endDate>2023-05-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i8b931c37fabd429398de685ab45b2d69_1"></div><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">W</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ASHINGTON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">, D.C. 20549</span></div><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc5_5a45b8f8-5cd4-47f9-8248-40318016d55a">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8zMTY_1979c318-bd53-4528-a69c-065dc5209602">May 19, 2023</ix:nonNumeric></span></div><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTgx_056fde23-22e6-4862-8b22-f7cbf8f8c88f">ARTIVION, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6ZTg5NWExMmQ1MjUyNGE3YjkzM2IwYjNmMjEwZWNjMjcvdGFibGVyYW5nZTplODk1YTEyZDUyNTI0YTdiOTMzYjBiM2YyMTBlY2MyN18wLTAtMS0xLTY1NzQy_d39dcbe3-305a-49eb-a4dd-6f76602c1489">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6ZTg5NWExMmQ1MjUyNGE3YjkzM2IwYjNmMjEwZWNjMjcvdGFibGVyYW5nZTplODk1YTEyZDUyNTI0YTdiOTMzYjBiM2YyMTBlY2MyN18wLTEtMS0xLTY1NzQy_392d9aa3-f3ef-455e-830e-be52dc4bacbd">1-13165</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6ZTg5NWExMmQ1MjUyNGE3YjkzM2IwYjNmMjEwZWNjMjcvdGFibGVyYW5nZTplODk1YTEyZDUyNTI0YTdiOTMzYjBiM2YyMTBlY2MyN18wLTItMS0xLTY1NzQy_06dbd9c6-9ff1-4180-922f-29907fd266fc">59-2417093</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTgy_1115cc95-b97f-4664-af8c-33808f436ec6">1655 Roberts Boulevard, N.W.,</ix:nonNumeric> <ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc1_640a1222-7fe3-4cab-8bfe-55fe56058f5f">Kennesaw</ix:nonNumeric>, <ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc2_f0abe804-08cf-4188-9634-a1b0d74d78ea">Georgia</ix:nonNumeric> <ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF81Mjk_d943e569-2440-4fdf-8063-93faaee72dd7">30144</ix:nonNumeric></span></div><div style="text-align:center"><span style="font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive office) (zip code)</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Registrant's telephone number, including area code: (<ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF82Mzg_51c6e174-aa61-4370-8d77-60ddfed84039">770</ix:nonNumeric>) <ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc3_dcbc7d83-b7fa-48a8-a5b3-78ec376ad48c">419-3355</ix:nonNumeric></span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Name of each exchange <br/>on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6Mjc5NGVjMmZiMWY5NGM2ZmEzMzJkMmE1Nzg3ZWI2OTkvdGFibGVyYW5nZToyNzk0ZWMyZmIxZjk0YzZmYTMzMmQyYTU3ODdlYjY5OV8xLTAtMS0xLTY1NzQy_45e13f0f-5982-489f-9f0e-d68f9f51c221">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6Mjc5NGVjMmZiMWY5NGM2ZmEzMzJkMmE1Nzg3ZWI2OTkvdGFibGVyYW5nZToyNzk0ZWMyZmIxZjk0YzZmYTMzMmQyYTU3ODdlYjY5OV8xLTEtMS0xLTY1NzQy_7d0166b0-db06-4b62-9702-3137a0355ae1">AORT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6Mjc5NGVjMmZiMWY5NGM2ZmEzMzJkMmE1Nzg3ZWI2OTkvdGFibGVyYW5nZToyNzk0ZWMyZmIxZjk0YzZmYTMzMmQyYTU3ODdlYjY5OV8xLTItMS0xLTY1NzQy_7a177fb3-1950-4689-bd22-aa1ed0990bcd">NYSE</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">___________________________________________</span></div><div style="margin-top:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF8wLTAtMS0xLTY1NzQy_feca1a17-7645-4b2d-8fd7-2b353f876e1f">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF8yLTAtMS0xLTY1NzQy_5f068740-de3c-46cf-b224-9f8d36a96979">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF80LTAtMS0xLTY1NzQy_0d6ff4f6-637b-4403-9a93-4833d8d43e12">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF82LTAtMS0xLTY1NzQy_7e874443-660f-4fbc-ab5f-c1c6f1cc0fa6">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc4_009f953b-a8a4-4a87-8511-d17de6064b3e">&#9744;</ix:nonNumeric></span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i8b931c37fabd429398de685ab45b2d69_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Item 5.07</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Submission of Matters to a Vote of Security Holders</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">At Artivion, Inc.&#8217;s (the &#8220;Company&#8221; or &#8220;Artivion&#8221;) 2023 Annual Meeting of Stockholders held on May 16, 2023 (the &#8220;Annual Meeting&#8221;), Artivion&#8217;s stockholders elected each individual that was nominated for election as director of the Company to serve until the next annual meeting or until their successors are elected and qualified. The stockholders also (i) approved, by non-binding vote, the compensation paid to Artivion&#8217;s named executive officers, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion, (ii) approved, by non-binding vote, one-year frequency for stockholder advisory votes on the compensation paid to Artivion&#8217;s named executive officers, (iii) ratified the preliminary selection of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2023, and (iv) approved additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash Incentive Plan (the &#8220;Artivion ECIP&#8221;). The Artivion ECIP is filed as Exhibit 10.1 hereto and incorporated herein by reference.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The final results of the voting on each matter of business at the Annual Meeting are as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Election of Directors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.727%"><tr><td style="width:1.0%"></td><td style="width:27.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.684%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Votes Withheld</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thomas F. Ackerman</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,738,849</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1,051,052</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Daniel J. Bevevino</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">30,895,401</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">894,500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Marna P. Borgstrom</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,442,553</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">347,348</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">James W. Bullock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,573,959</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">215,942</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jeffrey H. Burbank</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">26,113,051</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5,676,850</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Elizabeth A. Hoff</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,680,711</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">109,190</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">J. Patrick Mackin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,435,076</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">354,825</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Jon W. Salveson</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,073,463</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">716,438</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Anthony B. Semedo</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">31,570,252</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">219,649</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3,436,309</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Approval, by non-binding vote, of the compensation paid to Artivion&#8217;s named executive officers, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.909%"><tr><td style="width:1.0%"></td><td style="width:22.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">27,174,737</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">4,460,348</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">154,816</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3,436,309</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Approval, by non-binding vote, of one-year frequency for stockholder advisory votes on the compensation paid to Artivion&#8217;s named executive officers</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.000%"><tr><td style="width:1.0%"></td><td style="width:17.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.752%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">1 Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">2 Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">3 Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">30,517,597</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">30,736</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">1,092,618</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">148,950</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3,436,309</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Ratification of the preliminary selection of Ernst &amp; Young LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2023</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.272%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Abstain</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">35,117,916</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">104,825</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3,469</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-2-</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">        </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Approval of additional funding of 3,040,000 shares for the Artivion, Inc. 2020 Equity and Cash Incentive Plan</span></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.909%"><tr><td style="width:1.0%"></td><td style="width:22.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Votes Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">30,752,663</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">886,740</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">150,498</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3,436,309</span></td></tr></table></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Item&#160;9.01(d)&#160;&#160;&#160;&#160;Exhibits</span></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.18pt">Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.688%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline" href="ex101-2020artivionequityan.htm">10</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline" href="ex101-2020artivionequityan.htm">.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Artivion, Inc. 2020 Equity and Cash Incentive Plan.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-3-</span></div></div></div><div id="i8b931c37fabd429398de685ab45b2d69_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, Artivion, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date: May&#160;19, 2023</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTIVION, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/ D. Ashley Lee</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">D. Ashley Lee</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive Vice President and</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-4-</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-2020artivionequityan.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7f96f7f9cc584b068a2b435b7267c221_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTIVION, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020 EQUITY AND CASH INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GENERAL</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purpose</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Artivion, Inc. 2020 Equity and Cash Incentive Plan (the &#8220;Plan&#8221;) has been established by Artivion, Inc. (the &#8220;Company&#8221;)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to (i) attract, retain, and reward persons eligible to participate in the Plan&#59; (ii) motivate Participants (as defined in Section 1.2 below), by means of appropriate incentives, to achieve annual and long-term goals&#59; (iii) provide equity compensation to Directors of the Company&#59; (iv) provide incentive compensation opportunities to employee Participants that are competitive with those of companies with whom the Company competes for talent&#59; and (iv) further align Participants&#8217; interests with those of the Company&#8217;s stockholders through compensation that is based on the Company&#8217;s common stock&#59; and thereby promote the long-term interests of the Company and its Subsidiaries, as Subsidiaries are defined in Section 11(i), including the growth in value of the Company&#8217;s equity and enhancement of long-term stockholder return. Pursuant to the Plan, Participants may receive Options, SARs, Other Stock Awards, or Cash-Based Awards, each as defined herein (collectively referred to as &#8220;Awards&#8221;).  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Participation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions of the Plan, the Committee (as defined in Section 8) shall determine and designate, from time to time, from among the Eligible Grantees, as defined in Section 11(f), those persons who will be granted one or more Awards under the Plan, and thereby become &#8220;Participants&#8221; in the Plan.  In the discretion of the Committee, a Participant may be granted any Award permitted under the provisions of the Plan, and more than one Award may be granted to a Participant.  Subject to the provisions of Section 8.2(e), Awards may be granted as alternatives to or replacement of awards outstanding under the Plan, or any other plan or arrangement of the Company or a Subsidiary (including a plan or arrangement of a business or entity, all or a portion of which is acquired by the Company or a Subsidiary).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;1.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operation, Administration, and Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The operation and administration of the Plan, including the Awards made under the Plan, shall be subject to the provisions of Section 7 (relating to operation and administration). Capitalized terms in the Plan shall be defined as set forth in the Plan (including the definition provisions of Section 11 of the Plan).</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPTIONS AND SARS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;The grant of an &#8220;Option&#8221; entitles the Participant to purchase shares of Stock at an Exercise Price established by the Committee. Options granted under this Section 2 may either be Incentive Stock Options (&#8220;ISOs&#8221;) or Non</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Options (&#8220;NQOs&#8221;), as determined in the discretion of the Committee.  An &#8220;ISO&#8221; is an Option that is intended to satisfy the requirements applicable to an &#8220;incentive stock option&#8221; described in Section 422(b) of the Code.  An &#8220;NQO&#8221; is an Option that is not intended to be an &#8220;incentive stock option&#8221; as that term is described in Section 422(b) of the Code.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:36.7pt"><font><br></font></div><div style="text-indent:71.3pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;A stock appreciation right (a &#8220;SAR&#8221;) entitles the Participant to receive, in cash or Stock (as determined in accordance with Subsection 2.5), value equal to (or otherwise based on) the excess of&#58; (a) the Fair Market Value (as defined in Section 11) of a specified number of shares of Stock at the time of exercise&#59; over (b) an Exercise Price established by the Committee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Exercise Price of each Option and SAR granted under this Section 2 shall be not less than 100% of the Fair Market Value of a share of Stock on the date of grant of the Award, unless a higher price is established by the Committee or determined by a method established by the Committee at the time the Option or SAR is granted.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  An Option and an SAR shall be exercisable in accordance with such terms and conditions and during such periods as may be established by the Committee, before or after grant.</font></div><div style="text-align:justify"><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> On January 4, 2022, the Company&#8217;s Board of Directors approved amending the Plan to reflect the Company&#8217;s name change from CryoLife, Inc. to Artivion, Inc., and the Company&#8217;s reincorporation from Florida to Delaware. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment of Option Exercise Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The payment of the Exercise Price of an Option granted under this Section 2 shall be subject to the following&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Subject to the following provisions of this Subsection 2.4, the full Exercise Price for shares of Stock purchased upon the exercise of any Option shall be paid at the time of such exercise (except that, in the case of an exercise arrangement approved by the Committee and described in paragraph 2.4(c), payment may be made as soon as practicable after the exercise).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;The Exercise Price shall be payable in cash or by tendering (by actual delivery of shares) unrestricted shares of Stock that are acceptable to the Committee, valued at Fair Market Value as of the day the shares are tendered, or in any combination of cash or shares, as determined by the Committee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;To the extent permitted by applicable law, a Participant may elect to pay the Exercise Price upon the exercise of an Option by irrevocably authorizing a third party to sell shares of Stock (or a sufficient portion of the shares) acquired upon exercise of the Option and remit to the Company a sufficient portion of the sale proceeds to pay the entire Exercise Price and any tax withholding resulting from such exercise.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Settlement of Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Shares of Stock delivered pursuant to the exercise of an Option or an SAR shall be subject to such conditions, restrictions and contingencies as the Committee may establish in the applicable Award Agreement.  Settlement of SARs may be made in shares of Stock (valued at their Fair Market Value at the time of exercise), in cash, or in a combination thereof, as determined in the discretion of the Committee.  The Committee, in its discretion, may impose such conditions, restrictions and contingencies with respect to shares of Stock acquired pursuant to the exercise of an Option or an SAR as the Committee determines to be desirable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;2.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restrictions on Options and SAR Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Each Option and SAR shall be subject to the following&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;The term of any Option or SAR granted under the Plan shall not exceed seven years from the date of grant.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b) &#160;&#160;&#160;&#160;No option or SAR shall carry dividend rights or dividend equivalent rights.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Any such Award shall be subject to such conditions, restrictions and contingencies as the Committee shall determine.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 3</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER STOCK AWARDS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.&#160;&#160;&#160;&#160;The term &#8220;Other Stock Awards&#8221; means any of the following&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;A &#8220;Stock Unit&#8221; Award is the grant of a right to receive shares of Stock in the future.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;A &#8220;Performance Share&#8221; Award is a grant of a right to receive shares of Stock or Stock Units, which is contingent on the achievement of performance or other objectives during a specified period.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;A &#8220;Restricted Stock&#8221; Award is a grant of shares of Stock, and a &#8220;Restricted Stock Unit&#8221; Award is the grant of a right to receive shares of Stock in the future, with such shares of Stock or right to future delivery of such shares of Stock subject to a risk of forfeiture or other restrictions that will lapse upon the achievement of one or more goals relating to completion of service by the Participant, or achievement of performance or other objectives, as determined by the Committee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;3.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restrictions on Other Stock Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Each Stock Unit Award, Restricted Stock Award, Restricted Stock Unit Award and Performance Share Award shall be subject to such conditions, restrictions and contingencies as the Committee shall determine.</font></div><div style="margin-top:12pt;text-align:center;text-indent:12.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 4</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CASH</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASED AWARDS</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Cash-Based Award&#8221; means a right or other interest granted to a Participant under Section 4.2 of the Plan that may be denominated or payable in cash, other than an Award pursuant to which the amount of cash is determined by reference to the value of a specific number of shares of Stock. For the avoidance of doubt, dividend equivalents constitute Cash</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based Awards.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;4.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant of Cash-Based Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Committee is authorized to grant Awards to Participants in the form of Cash</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based Awards, as deemed by the Committee to be consistent with the purposes of the Plan, subject to such vesting and other conditions as the Committee shall determine in its sole discretion.  At the time of the grant of Cash-Based Awards, the Committee may place restrictions on the payout or vesting of Cash-Based Awards that shall lapse, in whole or in part, only upon the attainment of Performance Goals.  The Committee shall determine the terms and conditions of such Awards at the date of grant.  The maximum dollar amount that may be covered by all Cash-Based Awards granted to any individual during any fiscal year under the Plan is $2 million for employees and $500,000 for non-employee directors.  At the discretion of the Committee, Cash-Based Awards under this Plan may be issued jointly under this Plan and any other cash incentive or similar plan of the Company&#59; provided, however, that if a Cash-Based Award is issued under this Plan and another plan of the Company, to the extent of a conflict in the provisions of this Plan and the other plan, the terms of this Plan shall control.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 5</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PERFORMANCE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASED COMPENSATION</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;5.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Grant of Performance-Based Compensation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Committee may determine that any Awards granted to a Covered Employee shall be considered performance-based compensation, in which case the provisions of this Section 5 shall apply.  When Awards are made under this Section 5, the Committee shall establish in writing (i) the objective Performance Goals that must be met, (ii) the period during which performance will be measured, (iii) the maximum amounts that may be paid if the Performance Goals are met, and (iv) any other conditions that the Committee deems appropriate.  </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;5.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Pre-establishment of Performance Goals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  Performance Goals will, barring unusual or compelling circumstances, be pre-established by the Committee in writing not later than 90 days after the commencement of the period of service to which the Performance Goal relates, provided that the outcome is substantially uncertain at the time the Committee actually established the goal. </font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;5.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Adjustments to Performance Goals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Committee in its sole discretion shall have the authority to make adjustments to the Performance Goals in recognition of unusual or non-recurring events affecting the Company or any Subsidiary of the Company or the financial statements of the Company or any Subsidiary of the Company, in response to anticipated or actual changes in applicable laws or regulations, including changes in generally accepted accounting principles or practices, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment or product line of a business, as applicable. In addition, the Committee may specify that certain equitable adjustments to the Performance Goals will be made during the applicable performance period, provided such specification occurs in writing.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;5.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Certification of Performance Results</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Committee shall certify the satisfaction of the Performance Goal for the applicable performance period specified in the Award agreement after the performance period ends and prior to any payment with respect to the Award. The Committee shall determine the amount, if any, to be paid pursuant to each Award based on the achievement of the Performance Goals and the satisfaction of all other terms of the Award agreement.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">&#160;&#160;&#160;&#160;5.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:133%">Payment Upon Death or Disability or Other Circumstances</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:133%">.  The Committee may authorize that Awards under this Section 5 shall be payable, in whole or in part, in the event of the Participant&#8217;s death or disability, or under other circumstances.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 6</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STOCK SUBJECT TO THE PLAN</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards Subject to Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Awards granted under the Plan shall be subject to the following&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Subject to the following provisions of this Subsection 6.1, the maximum number of shares of Stock that may be delivered to Participants and their beneficiaries under the Plan shall be 5,715,000 shares of Stock, plus the remainder of any shares available and issuable under the Plan as of May 16, 2023, less the number of non-forfeited shares of Stock subject to outstanding Awards that have been granted but not yet vested. Shares of Stock issuable hereunder may, in whole or in part, be authorized but unissued shares or shares of Stock that shall have been or may be reacquired by the Company in the open market, in private transactions or otherwise. Notwithstanding the foregoing, with respect to SARs that are settled in Stock, the aggregate number of shares of Stock subject to the SAR grant shall be counted against the shares available for issuance under the Plan as one share for every share subject thereto, regardless of the number of shares used to settle the SAR upon exercise. For every share of Stock awarded hereunder in respect of Other Stock Awards, the maximum number of shares reserved for grant hereunder shall be reduced by 1.5 shares.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Subject to adjustment in accordance with Subsections 6.2 and 6.3, the following additional maximums are imposed under the Plan&#58; the maximum number of shares of Stock that may be covered by Awards granted to any one individual pursuant to Section 2 (relating to Options and SARs) shall be 800,000 for employees and 75,000 for non-employee directors during any fiscal year and the maximum number of shares of Stock that may be covered by Other Stock Awards granted to any one individual pursuant to Section 3 shall be 500,000 for employees and 500,000 for non-employee directors during any fiscal year&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;To the extent any shares of Stock covered by an Award are not delivered to a Participant or beneficiary because the Award is forfeited or canceled, or the shares of Stock are not delivered because the Award is settled in cash, such shares shall not be deemed to have been delivered for purposes of determining the maximum number of shares of Stock available for delivery under the Plan.  To the extent that shares of Stock subject to Other Stock Awards, and the issuance of which reduced the maximum number of shares authorized for issuance under the Plan by 1.5 shares, are forfeited or cancelled, or if such an Award terminates or expires without a distribution of shares to the Participant, the number of shares of Stock remaining for Award grants hereunder shall be increased by 1.5 for each share forfeited, cancelled or otherwise not delivered. Shares of Stock shall not again be available if such shares are surrendered or withheld as payment of either the exercise price of an Award and&#47; or withholding taxes in respect of an Award.  Awards that are settled solely in cash shall not reduce the number of shares of Stock available for Awards. Upon the exercise of any Award granted in tandem with any other Award, such related Awards shall be cancelled to the extent of the number of shares of Stock as to which the Award is exercised and, notwithstanding the foregoing, such number of shares shall no longer be available for Awards under the Plan.  The maximum number of shares of Stock available for delivery under the Plan shall not be reduced for shares subject to plans assumed by the Company in an acquisition of an interest in another company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjustments for Changes in Capitalization</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If the outstanding shares of Stock are changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of any recapitalization, reclassification, stock split, stock dividend, combination, subdivision or similar transaction, or if the Company makes an extraordinary dividend or distribution to its stockholders (including without limitation to implement a spinoff) (each, a &#8220;Corporate Transaction&#8221;) then, subject to any required action by the stockholders of the Company, the number and kind of shares of Company stock available under the Plan or subject to any limit or maximum hereunder shall automatically be proportionately adjusted, with no action required on the part of the Committee or otherwise. Subject to any required action by the stockholders, the number and kind of shares covered by each outstanding Award, and the price per share in each such Award, shall also be automatically proportionately adjusted for any increase or decrease in the number of issued shares of the Company resulting from a Corporate Transaction or any other increase or decrease in the number of such shares, or any decrease in the value of such shares, effected without receipt of consideration by the Company.  Notwithstanding the foregoing, no fractional shares shall be issued or made subject to an Option, SAR or Other Stock Award in making </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the foregoing adjustments.  All adjustments made pursuant to this Section shall be final, conclusive and binding upon the holders of Options, SARs and Other Stock Awards.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Certain Mergers and Other Extraordinary Events</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If the Company merges or consolidates with another corporation, or if the Company is liquidated or sells or otherwise disposes of substantially all of its assets while unexercised Options or other Awards remain outstanding under this Plan, (A) subject to the provisions of clause (C) below, after the effective date of the merger, consolidation, liquidation, sale or other disposition, as the case may be, whether or not the Company is the surviving corporation, each holder of an outstanding Option or other Award shall be entitled, upon exercise of that Option or Award or in place of it, as the case may be, to receive, at the option of the Committee and in lieu of shares of Stock, (i) the number and class or classes of shares of Stock or other securities or property to which the holder would have been entitled if, immediately prior to the merger, consolidation, liquidation, sale or other disposition, the holder had been the holder of record of a number of shares of Stock equal to the number of shares of Stock as to which that Option may be exercised or are subject to the Award or (ii) shares of stock of the company that is the surviving corporation in such merger, consolidation, liquidation, sale or other disposition having a value, as of the date of payment under Subsection 6.3(i) as determined by the Committee in its sole discretion, equal to the value of the shares of Stock or other securities or property otherwise payable under Subsection 6.3(i)&#59; (B) whether or not the Company is the surviving corporation, if Options or other Awards have not already become exercisable, the Board of Directors may waive any limitations set forth in or imposed pursuant to this Plan so that all Options or other Awards, from and after a date prior to the effective date of that merger, consolidation, liquidation, sale or other disposition, as the case may be, specified by the Board of Directors, shall be exercisable in full&#59; and (C) all outstanding Options or SARs may be cancelled by the Board of Directors as of the effective date of any merger, consolidation, liquidation, sale or other disposition, provided that with respect to a merger or consolidation the Company is not the surviving company, and provided further that any optionee or SAR holder shall have the right immediately prior to such event to exercise his or her Option or SAR to the extent such optionee or holder is otherwise able to do so in accordance with this Plan or his or her individual Option or SAR agreement&#59; provided, further, that any such cancellation pursuant to this Section 6.3 shall be contingent upon the payment to the affected Participants of an amount equal to (i) in the case of any out</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">money Option or SAR, cash, property or a combination thereof having an aggregate value equal to the value of such Option or SAR, as determined by the Committee or the Board of Directors, as applicable, in its sole discretion, and (ii) in the case of an in</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">money Option or SAR, cash, property or a combination thereof having an aggregate value equal to the excess of the value of the per-share amount of consideration paid pursuant to the merger, consolidation, liquidation, sale or other disposition, as the case may be, giving rise to such cancellation, over the exercise price of such Option or SAR multiplied by the number of shares of Stock subject to the Option or SAR.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Any adjustments pursuant to this Subsection 6.3 shall be made by the Board or Committee, as the case may be, whose determination in that respect shall be final, binding and conclusive, regardless of whether or not any such adjustment shall have the result of causing an ISO to cease to qualify as an ISO.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in Par Value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  In the event of a change in the shares of the Company as presently constituted, which is limited to a change of all of its authorized shares with par value into the same number of shares with a different par value or without par value, the shares resulting from any such change shall be deemed to be the shares within the meaning of this Plan. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Limitation on Grantees&#8217; Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Except as hereinbefore expressly provided in this Section 6, a Participant shall have no rights by reason of any subdivision or consolidation of shares of stock of any class or the payment of any stock dividend or any other increase or decrease in the number of shares of stock of any class or by reason of any dissolution, liquidation, merger, or consolidation or spin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">off of assets or stock of another corporation, and any issue by the Company of shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Stock subject to an Award, unless the Committee shall otherwise determine.</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company Right and Power</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The grant of any Award pursuant to this Plan shall not adversely affect in any way the right or power of the Company (A) to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, (B) to merge or consolidate, (C) to dissolve, liquidate or sell or transfer all or any part of its business or assets or (D) to issue any bonds, debentures, preferred or other preference stock ahead of or affecting the Stock.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;6.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fractional Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  If any action described in this Section 6 results in a fractional share for any Participant under any Award hereunder, such fraction shall be completely disregarded, and the Participant shall be entitled only to the whole number of shares resulting from such adjustment.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 7</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OPERATION AND ADMINISTRATION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date&#59; Duration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Plan is effective as of the date of its initial approval by the stockholders of the Company at the 2020 Annual Meeting of Shareholders, to be held on May&#160;20, 2020. The Plan will have a duration of ten years from May 20, 2020, and provided that in the event of Plan termination, the Plan shall remain in effect so long as any Awards under it are outstanding&#59; provided further, however, that no Award may be granted under the Plan on a date that is more than ten years from May 20, 2020.   </font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Notwithstanding anything in the Plan to the contrary, all Options, SARs, and Other Awards (including, but not limited to, performance-based awards) shall vest or become exercisable no earlier than twelve months from the date on which such Award is granted, except for the Committee&#8217;s discretion to provide for accelerated vesting or exercisability in connection with death, disability, retirement, or events as described above at Section 6.3, and except that up to five percent (5%) of the aggregate number of shares of Stock authorized for issuance under the Plan may be issued pursuant to Options, SARs, and Other Awards without regard to the service vesting and exercisability requirements of this Section 7.2. The term of any Award granted under the Plan will not exceed seven years from the date of grant. &#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Uncertificated Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  To the extent that the Plan provides for issuance of stock certificates to reflect the issuance of shares of Stock, the issuance may be effectuated on a non</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">certificated basis, to the extent not prohibited by applicable law or the applicable rules of any stock exchange.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax Withholding</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  All distributions under the Plan are subject to withholding of all applicable taxes, and the Committee may condition the delivery of any shares or other benefits under the Plan on satisfaction of the applicable withholding obligations. The Committee, in its discretion, and subject to such requirements as the Committee may impose prior to the occurrence of such withholding, may permit such withholding obligations to be satisfied through cash payment by the Participant, through the surrender of shares of Stock which the Participant already owns, or through the surrender of unrestricted shares of Stock to which the Participant is otherwise entitled under the Plan, but only to the extent of the minimum amount required to be withheld under applicable law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Use of Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Subject to the overall limitation on the number of shares of Stock that may be delivered under the Plan, the Committee may use available shares of Stock as the form of payment for compensation, grants or rights earned or due under any other compensation plans or arrangements of the Company or a Subsidiary, including the plans and arrangements of the Company or a Subsidiary assumed in business combinations.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.6&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividends and Dividend Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  An Award, excluding Options and SAR Awards,  may provide the Participant with the right to receive dividend payments or dividend equivalent payments with respect to Stock subject to the Award (both before and after the Stock subject to the Award is earned or vested), which payments may be either made currently or credited to an account for the Participant, and may be settled in cash or Stock as determined by the Committee.  Any such settlements, and any such crediting of dividends or dividend equivalents or reinvestment in shares of Stock, may be subject to such conditions, restrictions and contingencies as the Committee shall establish, including the reinvestment of such credited amounts in Stock equivalents.  In the event an Award is conditioned on the achievement of one or more Performance Goals, any dividend payments or dividend equivalent payments will only be earned, vested or acquired to the extent the underlying Stock subject to the Award is earned, vested or acquired. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.7&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Awards may be settled through cash payments, the delivery of shares of Stock, the granting of replacement Awards, or any combination thereof as the Committee shall determine.  Any Award settlement, including payment deferrals, may be subject to such conditions, restrictions and contingencies as the Committee shall determine.  The Committee may permit or require the deferral of any Award payment, subject to such rules and procedures as it may establish.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.8&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transferability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Except as otherwise provided by the Committee, Awards under the Plan are not transferable except as designated by the Participant by will or by the laws of descent and distribution.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.9&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Form and Time of Elections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Unless otherwise specified herein, each election required or permitted to be made by any Participant or other person entitled to benefits under the Plan, and any permitted modification, or revocation thereof, shall be in writing filed with the Committee at such times, in such form, and subject to such restrictions and limitations, not inconsistent with the terms of the Plan, as the Committee shall require.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.10&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement with Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  An Award under the Plan shall be subject to such terms and conditions, not inconsistent with the Plan, as the Committee shall, in its sole discretion, prescribe. The terms and conditions of any Award to any Participant, other than cash awards, shall be reflected in such form of a written or electronic document as is determined by the Committee.  A copy of such document shall be made available to the Participant, and the Committee may, but need not, require that the Participant sign a copy of such document or otherwise indicate his or her consent. Such document is referred to in the Plan as an &#8220;Award Agreement&#8221; regardless of whether any Participant signature is required. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.11&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Action by Company or Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Any action required or permitted to be taken by the Company or any Subsidiary under this Plan shall be by action of its Board of Directors, or by action of one or more members of the Board (including a committee of the Board) who are duly authorized to act for the Board, or (except to the extent prohibited by applicable law or applicable rules of any stock exchange) by a duly authorized officer of such company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.12&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gender and Number</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Where the context admits, words in any gender shall include any other gender, words in the singular shall include the plural and the plural shall include the singular.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.13&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Limitation of Implied Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Neither a Participant nor any other person shall, by reason of participation in the Plan, acquire any right in or title to any assets, funds or property of the Company or any Subsidiary whatsoever, including, without limitation, any specific funds, assets, or other property which the Company or any Subsidiary, in its sole discretion, may set aside in anticipation of a liability under the Plan.  A Participant shall have only a contractual right to the Stock or amounts, if any, payable under the Plan, unsecured by any assets of the Company or any Subsidiary, and nothing contained in the Plan shall constitute a guarantee that the assets of the Company or any Subsidiary shall be sufficient to pay any benefits to any person.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;The Plan does not constitute a contract of employment, and selection as a Participant will not give any participating employee the right to be retained in the employ of the Company or any Subsidiary, nor any right or claim to any benefit under the Plan, unless such right or claim has specifically accrued under the terms of the Plan. Except as otherwise provided in the Plan, no Award under the Plan shall confer upon the holder thereof any rights as a stockholder of the Company prior to the date on which the individual fulfills all conditions for receipt of such rights.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.14&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Evidence</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Evidence required of anyone under the Plan may be by certificate, affidavit, document or other information which the person acting on it considers pertinent and reliable, and shall be signed, made or presented by the proper party or parties.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination of Employment Following Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  In the event that the employment of a Participant who is an employee of the Company or a Subsidiary is terminated by the Company during the six</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">month period following a Change in Control, all of such Participant&#8217;s outstanding Options and SARs may thereafter be exercised by the Participant, to the extent that such Options and SARs were exercisable as of the date of such termination of employment (x) for a period of six&#160;months from such date of termination or (y) until expiration of the stated term of such Option or SAR, whichever period is the shorter.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.16&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  It is intended that all Options and SARs granted under the Plan shall be exempt from the provisions of Section&#160;409A of the Code and that all Other Stock Awards under the Plan, to the extent that they constitute &#8220;non-qualified deferred compensation&#8221; within the meaning of Section&#160;409A of the Code, will comply with Section&#160;409A of the Code (and any regulations and guidelines </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">issued thereunder). The Plan and any Award Agreements issued hereunder may be amended in any respect deemed by the Board or the Committee to be necessary in order to preserve compliance with Section&#160;409A of the Code or any successor section of the Code.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.17&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regulations and Other Approvals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;The obligation of the Company to sell or deliver Stock with respect to any Award granted under the Plan or make any other distribution of benefits under the Plan shall be subject to all applicable laws, rules and regulations, including all applicable federal and state securities laws (including, without limitation, the requirements of the Securities Act of 1933) and all applicable requirements of any securities exchange or similar entity, and the obtaining of all such approvals by governmental agencies as may be deemed necessary or appropriate by the Committee.</font></div><div style="margin-top:18pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Each Award is subject to the requirement that, if at any time the Committee determines, in its absolute discretion, that the listing, registration or qualification of Stock issuable pursuant to the Plan is required by any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the grant of an Award or the issuance of Stock, no such Award shall be granted or payment made or Stock issued, in whole or in part, unless listing, registration, qualification, consent or approval, as applicable, has been effected or obtained free of any conditions not acceptable to the Committee.</font></div><div style="margin-top:18pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;In the event that the disposition of Stock acquired pursuant to the Plan is not covered by a then current registration statement under the Securities Act of 1933 and is not otherwise exempt from such registration, such Stock shall be restricted against transfer to the extent required by the Securities Act of 1933, as amended, or regulations thereunder, and applicable state securities laws, and the Committee may require a Participant receiving Stock pursuant to the Plan, as a condition precedent to receipt of such Stock, to represent to the Company in writing that the Stock acquired by such Participant is acquired for investment only and not with a view to distribution.</font></div><div style="margin-top:18pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;With respect to persons subject to Section 16 of the Securities and Exchange Act of 1934, as amended, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3.</font></div><div style="margin-top:18pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;7.18&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Awards to Employees Subject to Taxation Outside of the United States</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Without amending the Plan, Awards may be granted to Participants who are foreign nationals or who are employed outside the United States or both, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee, be necessary or desirable to further the purposes of the Plan. Such different terms and conditions may be reflected in Addenda to the Plan or in the applicable Award Agreement. However, no such different terms or conditions shall be employed if such terms or conditions constitute, or in effect result in, an increase in the aggregate number of shares which may be issued under the Plan or a change in the definition of Eligible Grantee.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 8</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMMITTEE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.1&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Administration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The authority to control and manage the operation and administration of the Plan shall be vested in a committee (the &#8220;Committee&#8221;) in accordance with this Section 8.  The Committee shall be selected by the Board and shall consist solely of two or more members of the Board who are non-employee Directors within the meaning of Rule 16b</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 under the Securities Exchange Act of 1934, as amended.  If the Committee does not exist, or for any other reason determined by the Board, the Board may take any action under the Plan that would otherwise be the responsibility of the Committee. Unless otherwise determined by the Board, Artivion&#8217;s Compensation Committee shall be designated as the &#8220;Committee&#8221; hereunder.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.2&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Powers of Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Committee&#8217;s administration of the Plan shall be subject to the following&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;Subject to the provisions of the Plan, the Committee will have the authority and discretion to select from among the Eligible Grantees those persons who shall receive Awards, to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">determine the time or times of receipt, to determine the types of Awards and the number or value of shares or amount of cash covered by the Awards, to establish the terms, conditions, performance criteria, restrictions, and other provisions of such Awards, and (subject to the restrictions imposed by Section&#160;9) to cancel or suspend Awards, and to waive or otherwise modify any vesting or other restrictions contained in awards. The Committee may also, without obtaining stockholder approval, amend any outstanding award to provide the holder thereof with additional rights or benefits of the type otherwise permitted by the Plan, including without limitation, extending the term thereof&#59; provided, however, that in no event may the term of any Option or SAR exceed seven years.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;The Committee will have the authority and discretion to interpret the Plan, to establish, amend, and rescind any rules and regulations relating to the Plan, to determine the terms and provisions of any Award Agreement made pursuant to the Plan, and to make all other determinations that may be necessary or advisable for the administration of the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;Any interpretation of the Plan by the Committee and any decision made by it under the Plan is final and binding on all persons.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;In controlling and managing the operation and administration of the Plan, the Committee shall take action in a manner that conforms to the certificate of incorporation and by-laws of the Company, and applicable state corporate law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;Subject to Section&#160;6.2 hereof, neither the Board, the Committee nor their respective delegates shall have the authority to (i) re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">price (or cancel and regrant) any Option, SAR or, if applicable, other Award at a lower exercise, base or purchase price, (ii) take any other action (whether in the form of an amendment, cancellation or replacement grant, or a cash</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">out of underwater options) that has the effect of repricing an Option, SAR or other Award, or (iii) grant any Option, SAR or other Award that contains a so-called &#8220;reload&#8221; feature under which additional Options, SARs or other Awards are granted automatically to the Grantee upon exercise of the original Option, SAR or Award, without in each instance first obtaining the approval of the Company&#8217;s stockholders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;Anything in the Plan to the contrary notwithstanding, neither the Board nor the Committee may accelerate the payment or vesting of any Option, SAR or other Award except in the event of death, disability, retirement or a Change in Control. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Delegation by Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  Except to the extent prohibited by applicable law or the applicable rules of a stock exchange, the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers hereunder, including without limitation, the power to designate Participants hereunder and determine the amount, timing and terms of Awards hereunder, to any person or persons selected by it, including without limitation, any executive officer of the Company. Any such allocation or delegation may be revoked by the Committee at any time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Information to be Furnished to Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The Company and Subsidiaries shall furnish the Committee with such data and information as it determines may be required for it to discharge its duties. The records of the Company and Subsidiaries as to an employee&#8217;s or Participant&#8217;s employment, termination of employment, leave of absence, reemployment and compensation shall be conclusive unless the Committee determines such records to be incorrect. Participants and other persons entitled to benefits under the Plan must furnish the Committee such evidence, data or information as the Committee considers desirable to carry out the terms of the Plan.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Each person who is or shall have been a member of the Committee, or the Board, shall be indemnified and held harmless by the Company against and from any loss, cost, liability or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company&#8217;s approval, or paid by him or her in satisfaction of any judgment in any such action, suit or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall be in addition to any other rights of indemnification or elimination of liability to which such persons may be entitled under the Company&#8217;s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 9</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMENDMENT AND TERMINATION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;The Plan may be terminated or amended by the Board of Directors at any time, except that the following actions may not be taken without stockholder approval&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;any increase in the number of shares that may be issued under the Plan (except by certain adjustments provided for under the Plan)&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;any change in the class of persons eligible to receive Awards under the Plan&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;any change in the requirements of Section 2.2 hereof regarding the Exercise Price of Options and SARs&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;any re</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pricing or cancellation and regrant of any Option or, if applicable, other Award at a lower exercise, base or purchase price, whether in the form of an amendment, cancellation or replacement grant, or a cash-out of underwater options or any action that provides for Awards that contain a so</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">called &#8220;reload&#8221; feature under which additional Options or other Awards are granted automatically to the Grantee upon exercise of the original Option or Award&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;any other amendment to the Plan that would require approval of the Company&#8217;s stockholders under applicable law, regulation or rule.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding any of the foregoing, adjustments pursuant to paragraph 6.2 shall not be subject to the foregoing limitations of this Section 9.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Options, SARs and other Awards may not be granted under the Plan after the date of termination of the Plan, but Options and SARs granted prior to that date shall continue to be exercisable according to their terms and other Awards shall continue to vest in accordance with their terms.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 10</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHANGE IN CONTROL </font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Subject to the provisions of paragraph 6.2 (relating to the adjustment of shares), and except as otherwise provided in the Plan or the Award Agreement reflecting the applicable Award, upon the occurrence of a Change in Control as defined in Section 11&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;All outstanding Options (regardless of whether in tandem with SARs) shall become fully exercisable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;All outstanding SARs (regardless of whether in tandem with Options) shall become fully exercisable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;All Stock Units, Restricted Stock, Restricted Stock Units, Performance Shares and other Awards, other than Cash-Based Awards, shall become fully vested.  Whether or not Cash</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based Awards shall vest upon a Change in Control shall be determined by the Committee in its discretion, either at or after grant.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 11</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFINED TERMS</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;In addition to the other definitions contained herein, the following definitions shall apply&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Award&#8221; shall mean any award or benefit granted under the Plan, including, without limitation, the grant of Options, SARs, Other Stock Awards and Cash-Based awards.</font></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Board&#8221; shall mean the Board of Directors of the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  &#8220;Change in Control&#8221; means a change in the ownership or effective control of, or in the ownership of a substantial portion of the assets of, the Company, as described in paragraphs (i) through (iii) below.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Ownership of the Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  A change in the ownership of the Company shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)), acquires ownership of the Company stock that, together with the Company stock held by such person or group, constitutes more than 50% of the total voting power of the stock of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;If any one person or more than one person acting as a group (within the meaning of paragraph (iv) below), is considered to own more than 50% of the total voting power of the stock of the Company, the acquisition of additional the Company stock by such person or persons shall not be considered to cause a change in the ownership of the Company or to cause a change in the effective control of the Company (within the meaning of paragraph (ii) below).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;An increase in the percentage of the Company stock owned by any one person, or persons acting as a group (within the meaning of paragraph (iv) below), as a result of a transaction in which the Company acquires its stock in exchange for property, shall be treated as an acquisition of stock for purposes of this paragraph (i).</font></div><div style="text-align:justify;text-indent:13.5pt"><font><br></font></div><div style="text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(C)&#160;&#160;&#160;&#160;Except as provided in (B) above, the provisions of this paragraph (i)&#160;shall apply only to the transfer or issuance of the Company stock if such stock remains outstanding after such transfer or issuance.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Effective Control of the Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;A change in the effective control of the Company shall occur on the date that either of (1) or (2) below occurs&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;Any one person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below), acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by such person or persons) ownership of stock of the Company possessing 30% or more of the total voting power of the stock of the Company&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;A majority of the members of the Board are replaced during any 12-month period by Directors whose appointment or election is not endorsed by a majority of the Board prior to the date of the appointment or election.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;A change in effective control of the Company also may occur with respect to any transaction in which either of the Company or the other entity involved in a transaction experiences a Change of Control event described in paragraphs (i) or (iii).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(C)&#160;&#160;&#160;&#160;If any one person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below), is considered to effectively control the Company (within the meaning of this paragraph (ii)), the acquisition of additional control of the Company by the same person or persons shall not be considered to cause a change in the effective control of the Company (or to cause a change in the ownership of the Company within the meaning of paragraph (i) above).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in Ownership of a Substantial Portion of the Company&#8217;s Assets</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  A change in the ownership of a substantial portion of the Company&#8217;s assets shall occur on the date that any one person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below), acquires (or has acquired during the 12 month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value (within the meaning of paragraph (iii)(B)) equal to or more than 40% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(A)&#160;&#160;&#160;&#160;A transfer of the Company&#8217;s assets shall not be treated as a change in the ownership of such assets if the assets are transferred to one or more of the following&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;A shareholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company stock&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;An entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company&#59;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(3)&#160;&#160;&#160;&#160;A person, or more than one person acting as a group (within the meaning of paragraph (iv)&#160;below) that owns, directly or indirectly, 50% or more of the total value or voting power of all of the outstanding stock of the Company&#59; or</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(4)&#160;&#160;&#160;&#160;An entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a person described in paragraph (iii)(A)(3).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For purposes of this paragraph (iii)(A), and except as otherwise provided, a person&#8217;s status is determined immediately after the transfer of assets.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(B)&#160;&#160;&#160;&#160;For purposes of this paragraph (iii), gross fair market value means the value of all the Company assets, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;For purposes of this Section 11(c), persons shall be considered to be acting as a group if they are owners of an entity that enters into a merger, consolidation, purchase, or acquisition of assets, or similar business transaction with the Company.  If a person, including an entity shareholder, owns stock in the Company and another entity with which the Company enters into a merger, consolidation, purchase, or acquisition of stock, or similar business transaction, such shareholder shall be considered to be acting as a group with the other shareholders in a corporation only to the extent of the ownership in that corporation prior to the transaction giving rise to the change and not with respect to the ownership interest in the other corporation.  Persons shall not be considered to be acting as a group solely because they purchase or own stock of the Company at the same time, or as a result of the same public offering of the Company&#8217;s stock.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Code&#8221; means the Internal Revenue Code of 1986, as amended. A reference to any provision of the Code shall include reference to any successor provision of the Code.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Covered Employee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Covered Employee&#8221; means an Eligible Grantee who is, or who is anticipated to become, between the time of grant and payment of the Award, a &#8220;covered employee,&#8221; as such term is defined in Section 162(m)(3) of the Code (or any successor section thereof).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eligible Grantee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">. The term &#8220;Eligible Grantee&#8221; shall mean any director, officer, employee, consultant, or agent of the Company or a Subsidiary, as determined by the Committee in its sole discretion. An Award may be granted to an eligible grantee, in connection with hiring, retention or otherwise, prior to the date the eligible grantee first performs services for the Company or the Subsidiaries, provided that such Award shall not become vested prior to the date the eligible grantee first performs such services or the director assumes his position.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Market Value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  For purposes of determining the &#8220;Fair Market Value&#8221; of a share of Stock as of any date, then the &#8220;Fair Market Value&#8221; as of that date shall be the closing sale price of the Stock on that date on the New York Stock Exchange.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Goals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Performance Goals&#8221; means performance goals based on the attainment by the Company or any Subsidiary of the Company (or any division or business unit of any such entity), or any two or more of the foregoing, of performance goals established by the Committee in its sole discretion, based on one or more of the following criteria, which shall not be required to be calculated in accordance with GAAP and which may be adjusted measures&#58; (1) return on total stockholders&#8217; equity&#59; (2) earnings per share of Stock&#59; (3) earnings before any or all of interest, taxes, minority interest, depreciation and amortization&#59; (4) economic profit&#59; (5) sales or revenues&#59; (6) return on assets, capital or investment&#59; (7) market share&#59; (8) control of operating or non-operating expenses&#59; (9) reductions in certain costs (including reductions in inventories or accounts receivable or reductions in operating expenses)&#59; (10) operating profit&#59; (11) operating cash flow&#59; (12) free cash flow&#59; (13) return on capital or increase in pretax earnings&#59; (14) net earnings&#59; (15) margins&#59; (16) market price of the Company&#8217;s securities&#59; (17) pre-tax earnings&#59; (18) net after</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">tax earnings per share&#59; (19) working capital targets&#59; (20) working capital and the ratio of sales to net working capital&#59; (21) earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;)&#59; (22) sales of one or more products or service offerings&#59; (23) control of operating and&#47;or non-operating expenses&#59; (24) any combination of, or a specified increase in, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any of the foregoing&#59; and (25) general comparisons with other peer companies or industry groups or classifications with regard to one or more of the foregoing criteria. The relative weights of the criteria that comprise the Performance Goals shall be determined by the Committee in its sole discretion. In establishing the Performance Goals for a performance period, the Committee may establish different Performance Goals for individual Participants or groups of Participants.  Subject to the limitations in Section 5, the Committee in its sole discretion shall have the authority to make equitable adjustments to the Performance Goals in recognition of unusual or non-recurring events affecting the Company or any Subsidiary of the Company or the financial statements of the Company or any Subsidiary of the Company, in response to changes in applicable laws or regulations, including changes in generally accepted accounting principles or practices, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment of a business, as applicable, or otherwise as the Committee deems appropriate.  Performance Goals may include a threshold level of performance below which no Award will be earned, a level of performance at which the target amount of an Award will be earned and a level of performance at which the maximum amount of the Award will be earned.  &#8220;Performance Goals&#8221; shall also mean any other factors directly tied to the performance of the Company and&#47;or one or more divisions and&#47;or Subsidiaries or other performance criteria designated by the Committee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Subsidiary&#8221; means any present or future subsidiary corporation of the Company within the meaning of Section 424(f) of the Code, and any present or future business venture designated by the Committee in which the Company has a significant interest, as determined in the discretion of the Committee.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.  The term &#8220;Stock&#8221; shall mean shares of common stock of the Company.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SECTION 12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOVERNING LAW</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Plan shall be governed by, and construed in accordance with, the laws of the State of Delaware.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aort-20230519.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dbb8ef44-ff75-4ea4-a34d-496f46f68ada,g:82f8bde6-0e78-4319-9a8d-c7fab6609d31-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:aort="http://www.cryolife.com/20230519" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cryolife.com/20230519">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20230519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20230519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cryolife.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aort-20230519_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dbb8ef44-ff75-4ea4-a34d-496f46f68ada,g:82f8bde6-0e78-4319-9a8d-c7fab6609d31-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_4344b509-7ffc-4d05-9d02-9ca38b83115c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3b6945db-c600-459d-9b78-276dad8af0b5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_060c3f79-7594-482f-baaa-caaee58cf8da_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_1c289077-1aa7-4f87-ba13-c2c42492afb8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_23657711-e5f1-4d12-94d9-ae43e31c52a0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_858dc343-a962-4b6a-8533-710bf8897095_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_4f7211cf-77fb-455a-b32d-a485c490c359_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_deaa0485-c86f-4815-bbc2-a979965be6c4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_895c62e0-a0f2-4a14-a757-cb5d69d4e436_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e650c7f9-6121-4ffd-a922-3400a1c1e66e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cac6a819-50c8-464c-8c8b-39a19fee0de1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_50426cca-7dee-4de7-b1b1-9617488bbc25_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_69b5a09d-fd15-4dc5-8c19-c91215a6669a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a76ff09d-7c94-4a9e-832d-b76a82826547_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_6e50a32e-0bf0-44ef-a344-76386b517378_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d1c42a81-22be-41a6-9c27-a3cca06399d0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a887a871-bcc9-427f-ab62-7fb1faaabb91_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_4919df0d-dbd0-4acb-9bbd-982bf26328cb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_37d1065f-cbb2-4ad0-a576-6e3cb4dc144b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dd2b1172-a974-4095-b34e-1ea60d0308a9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_afafd8f5-ca20-4c6e-938a-89035eff534d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_6c24eda9-37eb-412c-8967-b4ad51e57ef8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aort-20230519_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dbb8ef44-ff75-4ea4-a34d-496f46f68ada,g:82f8bde6-0e78-4319-9a8d-c7fab6609d31-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cryolife.com/role/Cover" xlink:type="simple" xlink:href="aort-20230519.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_18df6127-3c46-4f13-87b7-366f40160ea3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_DocumentType_18df6127-3c46-4f13-87b7-366f40160ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_155fde97-365d-4966-8755-bbbf06368bb1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_DocumentPeriodEndDate_155fde97-365d-4966-8755-bbbf06368bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_ed5fe38e-f419-4a45-9fea-69fc0f453089" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityRegistrantName_ed5fe38e-f419-4a45-9fea-69fc0f453089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3e66cd1e-eccc-461c-a9a5-6699d66b6767" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3e66cd1e-eccc-461c-a9a5-6699d66b6767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b0f2a726-d8a7-46cb-83e2-471ab7882456" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityFileNumber_b0f2a726-d8a7-46cb-83e2-471ab7882456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_449c7326-29e6-40af-b992-82e0eb90f8ad" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityTaxIdentificationNumber_449c7326-29e6-40af-b992-82e0eb90f8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_49eea1b6-e3c1-45f6-83c3-e2b12cb34d07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityAddressAddressLine1_49eea1b6-e3c1-45f6-83c3-e2b12cb34d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b70a78f1-295a-49ea-a922-c29fb551ad16" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityAddressCityOrTown_b70a78f1-295a-49ea-a922-c29fb551ad16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_0cabd9a3-62e0-47a6-bd1a-878d41035e3c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityAddressStateOrProvince_0cabd9a3-62e0-47a6-bd1a-878d41035e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_652bbb3f-0fc1-42e5-b3b9-378ef5e318da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityAddressPostalZipCode_652bbb3f-0fc1-42e5-b3b9-378ef5e318da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_45f82286-3d65-45d3-b2d7-130ca35feb33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_CityAreaCode_45f82286-3d65-45d3-b2d7-130ca35feb33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bf5c64e5-6d70-4f44-87f7-894c0772dc74" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_LocalPhoneNumber_bf5c64e5-6d70-4f44-87f7-894c0772dc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_3411365d-2ded-4c15-bd49-9974bd64b1c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_Security12bTitle_3411365d-2ded-4c15-bd49-9974bd64b1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a934117b-6a89-4c1e-acf7-2f88989d0be8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_TradingSymbol_a934117b-6a89-4c1e-acf7-2f88989d0be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_bfd46452-d29b-497f-8194-c86a1a854fea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_SecurityExchangeName_bfd46452-d29b-497f-8194-c86a1a854fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e19104cb-fdb0-4f8c-9a14-3119d3a7c0eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_WrittenCommunications_e19104cb-fdb0-4f8c-9a14-3119d3a7c0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_58cf81dd-e787-468e-a843-03e7da1256a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_SolicitingMaterial_58cf81dd-e787-468e-a843-03e7da1256a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_638d3396-2183-4385-ac2a-687ba70eec31" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_PreCommencementTenderOffer_638d3396-2183-4385-ac2a-687ba70eec31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_409cc615-f165-45e0-8204-8b601d3492ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_409cc615-f165-45e0-8204-8b601d3492ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_708269d2-2888-4c69-a7be-a81fb7e022dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityEmergingGrowthCompany_708269d2-2888-4c69-a7be-a81fb7e022dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9a59604c-83bc-4039-a956-223e2a461d86" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_EntityCentralIndexKey_9a59604c-83bc-4039-a956-223e2a461d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_a7a064a8-50ff-41ca-a09a-39b7052125a3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_dec978c8-8df5-41bf-a008-eeb3da8d691b" xlink:to="loc_dei_AmendmentFlag_a7a064a8-50ff-41ca-a09a-39b7052125a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139681688467072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARTIVION, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2417093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1655 Roberts Boulevard, N.W.,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kennesaw<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">419-3355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AORT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000784199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>aort-20230519_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aort-20230519.xsd" xlink:type="simple"/>
    <context id="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2023-05-19</startDate>
            <endDate>2023-05-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV80L2ZyYWc6MWVmZDUwOTdhZGU5NGZmMWFlNzYyZjQ1ZGQzZmY0YjcvdGFibGU6OTdhOWRiNDVjOTIxNDQ3ZGFjZmM0MzUxYWEwMjZlYjkvdGFibGVyYW5nZTo5N2E5ZGI0NWM5MjE0NDdkYWNmYzQzNTFhYTAyNmViOV8wLTEtMS0xLTY1NzQy_e0449943-ceb3-4b22-9cfe-a20e07a4b3ef">0000784199</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV80L2ZyYWc6MWVmZDUwOTdhZGU5NGZmMWFlNzYyZjQ1ZGQzZmY0YjcvdGFibGU6OTdhOWRiNDVjOTIxNDQ3ZGFjZmM0MzUxYWEwMjZlYjkvdGFibGVyYW5nZTo5N2E5ZGI0NWM5MjE0NDdkYWNmYzQzNTFhYTAyNmViOV8xLTEtMS0xLTY1NzQy_b8be5793-6eea-4bd4-834e-840efff147d9">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc5_5a45b8f8-5cd4-47f9-8248-40318016d55a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8zMTY_1979c318-bd53-4528-a69c-065dc5209602">2023-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTgx_056fde23-22e6-4862-8b22-f7cbf8f8c88f">ARTIVION, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6ZTg5NWExMmQ1MjUyNGE3YjkzM2IwYjNmMjEwZWNjMjcvdGFibGVyYW5nZTplODk1YTEyZDUyNTI0YTdiOTMzYjBiM2YyMTBlY2MyN18wLTAtMS0xLTY1NzQy_d39dcbe3-305a-49eb-a4dd-6f76602c1489">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6ZTg5NWExMmQ1MjUyNGE3YjkzM2IwYjNmMjEwZWNjMjcvdGFibGVyYW5nZTplODk1YTEyZDUyNTI0YTdiOTMzYjBiM2YyMTBlY2MyN18wLTEtMS0xLTY1NzQy_392d9aa3-f3ef-455e-830e-be52dc4bacbd">1-13165</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6ZTg5NWExMmQ1MjUyNGE3YjkzM2IwYjNmMjEwZWNjMjcvdGFibGVyYW5nZTplODk1YTEyZDUyNTI0YTdiOTMzYjBiM2YyMTBlY2MyN18wLTItMS0xLTY1NzQy_06dbd9c6-9ff1-4180-922f-29907fd266fc">59-2417093</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTgy_1115cc95-b97f-4664-af8c-33808f436ec6">1655 Roberts Boulevard, N.W.,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc1_640a1222-7fe3-4cab-8bfe-55fe56058f5f">Kennesaw</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc2_f0abe804-08cf-4188-9634-a1b0d74d78ea">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF81Mjk_d943e569-2440-4fdf-8063-93faaee72dd7">30144</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF82Mzg_51c6e174-aa61-4370-8d77-60ddfed84039">770</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc3_dcbc7d83-b7fa-48a8-a5b3-78ec376ad48c">419-3355</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6Mjc5NGVjMmZiMWY5NGM2ZmEzMzJkMmE1Nzg3ZWI2OTkvdGFibGVyYW5nZToyNzk0ZWMyZmIxZjk0YzZmYTMzMmQyYTU3ODdlYjY5OV8xLTAtMS0xLTY1NzQy_45e13f0f-5982-489f-9f0e-d68f9f51c221">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6Mjc5NGVjMmZiMWY5NGM2ZmEzMzJkMmE1Nzg3ZWI2OTkvdGFibGVyYW5nZToyNzk0ZWMyZmIxZjk0YzZmYTMzMmQyYTU3ODdlYjY5OV8xLTEtMS0xLTY1NzQy_7d0166b0-db06-4b62-9702-3137a0355ae1">AORT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6Mjc5NGVjMmZiMWY5NGM2ZmEzMzJkMmE1Nzg3ZWI2OTkvdGFibGVyYW5nZToyNzk0ZWMyZmIxZjk0YzZmYTMzMmQyYTU3ODdlYjY5OV8xLTItMS0xLTY1NzQy_7a177fb3-1950-4689-bd22-aa1ed0990bcd">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF8wLTAtMS0xLTY1NzQy_feca1a17-7645-4b2d-8fd7-2b353f876e1f">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF8yLTAtMS0xLTY1NzQy_5f068740-de3c-46cf-b224-9f8d36a96979">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF80LTAtMS0xLTY1NzQy_0d6ff4f6-637b-4403-9a93-4833d8d43e12">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGFibGU6OTBhMzE5ZDlmNjg1NDE2ODkzMjQwYzZmOGVkNjZlNDQvdGFibGVyYW5nZTo5MGEzMTlkOWY2ODU0MTY4OTMyNDBjNmY4ZWQ2NmU0NF82LTAtMS0xLTY1NzQy_7e874443-660f-4fbc-ab5f-c1c6f1cc0fa6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519"
      id="id3VybDovL2RvY3MudjEvZG9jOjhiOTMxYzM3ZmFiZDQyOTM5OGRlNjg1YWI0NWIyZDY5L3NlYzo4YjkzMWMzN2ZhYmQ0MjkzOThkZTY4NWFiNDViMmQ2OV8xL2ZyYWc6M2EyYjVjMWJmNWY0NDdmODk3OWU2OGFiZTExNTU0NzAvdGV4dHJlZ2lvbjozYTJiNWMxYmY1ZjQ0N2Y4OTc5ZTY4YWJlMTE1NTQ3MF8xNTc4_009f953b-a8a4-4a87-8511-d17de6064b3e">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !;8[-6N\5?T3P$  !O$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)6886_J-A2&_XJ53=,F48@#E-(!$N6V=ZBW% &[U3;M@TD,6$WL7,>!\N]W
M'"!ANN&$RP<2)SDOC\^Q7\?T=DJ_)QO.#?F(0IGTG8TQ\7VCD?@;'K&DKF(N
MX<Y*Z8@9:.IU(XDU9T$6%(4-SW5O&Q$3TAGTLFM3/>BIU(1"\JDF21I%3.\?
M>*AV?8<ZIPLSL=X8>Z$QZ,5LS>?<_!E/-;0:N4H@(BX3H231?-5WAO3^P6O9
M@.R)KX+ODK-S8KNR5.K=-L9!WW$M$0^Y;ZP$@\.6CW@86B7@^'84=?+?M('G
MYR?UIZSST)DE2_A(A6\B,)N^<^>0@*]8&IJ9VOW!CQUJ6SU?A4GV37:'9ULM
MA_AI8E1T# :"2,C#D7T<$W$6T'0O!'C' "_C/OQ01OF)&3;H:;4CVCX-:O8D
MZVH6#7!"VJK,C8:[ N+,8*2V7/<:!J3LA89_#'LXA'D7PE[8GM!NC7BNU_Q_
M= , <@HOI_ RN29&0?X9+A.CH4[_E@$=%%KE"G;PWB<Q\WG?@=&9<+WESN"7
MG^BM^SO"U\SYFICZX)/R4QB*ABSV,2^#P\/O;IX1B%8.T;H.8LJU4 %YE &!
MFI?RX$JGZE65KYV3M5&]1VF$V9,97PM;0$"<L*B4"]<9SA;CK^/728V,)Z,Z
M G:;@]U> S:6OM*QTLP:08W,#62-*$U&*I5&[^$8E-+BXI\>$<).3MBYAO!)
MA)Q,TFA9/AEQ#7I#F_2VC=#<Y31WU] LV <9!S#4Q$KX6=(0-ERQW;WQ6K3C
M=K%QULWQNM?@#8, IGA2.YV0+_ <>96E-<05(6UM,E/0-9.0!Y6&?,MT4".3
M^EN]AA!3M_!7]X>81[8%8V^A=K+4=W&Y9RXE3]@.8SOS?OI#;/G$F&JU%=(O
M36B%YN<AAE8L"!3U\^_0IBHQ+"1_B_CB;*U0;+JTU<+8BL6 XG:>E7 ([T"7
M47"!3L?%0(H%@>(^_D7YD)/I1DG,/"I$6K1[TVRV,?N@Q4) <0=?" -&IE:$
M>K\N?R-S[J<:LE6*A2N-5!2![\R-\M]KY&>W[E(2,TVV+$PYQEJL#13W[X5F
M@9!K,M]'2Q66(N("P]?9 B,IU@"*&_@I3>3QP]\PN>87U\\*H<E?<VQ1HL4Z
M0'';?@,<PR6Q54CE<1%(2HEPH14+$[1<A?=3W*KG*A2^,+9B+V!36K#RFN$J
M53Q>8>P>[L13S6]\2 \'GSR\&W(9P%OLZVI5/@\K]"K)"EOW< O^CFR<)"F0
M50+BLI6 9V_[5YG[8\3UVM;S,RB8C1UL,9.E9E$A6(E6>+N'6_,1;01IT^"M
M8\C8!WGFY5"XE N?SAW8:Q<C*\S>PWUZ"*4,LG(^A6Q=RH,+7$Q2XVS[:+?B
M+\R6)2$A7X&06^^ 4^O#[O;0,"K.=I1+96!_FIUN.(.Q91^ ^RNES*EA-ZGY
M?PR#_P!02P,$%     @ 6V.S5I^@&_"Q @  X@P   T   !X;"]S='EL97,N
M>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG
M:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<
M>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6
ME :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,H
MH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+
M3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC
M%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/
MQGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8
M\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W
M5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\
M*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76
M^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1G
MA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ
M;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:
M0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#
MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ 6V.S5I>*NQS     $P(   L
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MU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ 6V.S5B0>FZ*M    ^ $  !H
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M_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%
M  @ 6V.S5@=!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " !;8[-6D"6=:>\    K @  $0
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M<R\N<F5L<U!+ 0(4 Q0    ( %MCLU:JQ"(6,P$  "("   /
M  "  440  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !;8[-6)!Z;HJT
M  #X 0  &@              @ &E$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " !;8[-699!YDAD!  #/ P  $P
M@ &*$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #4$P
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="aort-20230519.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="aort-20230519.htm">aort-20230519.htm</File>
    <File>aort-20230519.xsd</File>
    <File>aort-20230519_lab.xml</File>
    <File>aort-20230519_pre.xml</File>
    <File>ex101-2020artivionequityan.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aort-20230519.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "aort-20230519.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aort-20230519_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aort-20230519_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aort-20230519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "aort",
   "nsuri": "http://www.cryolife.com/20230519",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230519.htm",
      "contextRef": "if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cryolife.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230519.htm",
      "contextRef": "if7a70fd48efd43a7b7a21520789670d4_D20230519-20230519",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000784199-23-000092-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000784199-23-000092-xbrl.zip
M4$L#!!0    ( %MCLU8CZ[.' AD  .'E   1    86]R="TR,#(S,#4Q.2YH
M=&WM/6MWVKBVW\^OT&7NG4G70D3RV[3-66E"4CH%VH24@2]=LB4')\9F;)-
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MI'X:B"T6Q2F6"DMT:G_8S%]^V,Q!.Q$?;7W@_AE*TE$@/A:XG_0#-BJ'42@
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MR7QAF=M%+BADLJSC?/<0&+,L]C@<]9PHV$B6=ACS;I-3'R_XR,0GAKEY0?D
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M+Q4$VDHNE0,4HA*'28K^9+W^>]2&J.H8??WZ36J-K"5[<%]DW?C:JFJ(L)P
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M:94*SAZQG87/[?K\*HZ3,W)$J4ITE2%YJU^>54F\K]JK[=R5YUXP[UKLS[4
M.*"4/!EKS// />\+C/QDE3('AW<W+OE ZU2B(9$+X^,RY7&[>(R(%$OK;60H
M&MS>P[TQ7:'3M,J8U318%94G7 1NBLC9$XHDN0@:^F81OD#0\2?*K6OT $B%
MZZ\88!#(=0ZEA7]X"9E3A>2JYR=%FB]TR44$>F2<G$4.A(57SN&E5"4PY?MD
M4J\"[%(G!+:S/D >:#]7>]4;(8%YQZ+YJ&6"3]_IFS8\]Z8N+IZK %(9EK40
M--PSMLY6Q2Q'#GP9@ 9$9A27=+U)_&3=4AS2[@;AFP\)K#"Y&6HO?;AQC4GT
MT#'M+^B!D\) [+$GP2R?IJ=(N=^)#8'H$6B#:YN<0(HMD3)5 ]H,K:-7;/!;
M^%S3/'6&1R6R@I(^<L< B!E"+"@.1B8#,8WY:!J?Y*232)F0<KJ=[9)!G#<(
MTGIL" TQ4>1.E.17UUWYP-'''>#A4Q5?9)ATGQ^I(]OD<YR!K[>B$3K*647^
M&&9K,3AWYTB:0CW>](2] &J*M/O:2;73A5%Z'K,7_.E.5 A1(2BJF;R:VI;?
M7;$<*14A'8AF%5SY9Q\AOK;>)HU)QSEC((,^%KW%"#UM?3V%J[GQ65:'):_=
M$GN7<3%[T8C5UJ=MZ88H\X"7Y)]8:=A*60[Z:Z<">[\ZV3K?AD.BS0ONS>L+
MYU&86I(V+;;LXXNF P%]-QV#]H>85S5<=TM5]09!H+4T]LFC'_;OK@:FE!0V
MG2T=E8/M\>$VW4"5L&V@L<!2<:T,#ILYR5SS4N.$>ZT]S21"J4]NX_9HW6**
MWBI32[.J:31L=<_4O1AHFVKFS59!:&JMGZ]T[<!'[ 82K\\Y9V[7O^B6 B3J
M#".N?HI/5CF"(4OP4._1=]>.OONJRD]*_EO'![5MR%9T_:/T;J-$ ;[+JO@;
MZ8(WIF0(M I!2'=CUNTPX<T!AS)#HG>RA/#PH9U4L<=0GPHI5>X;GZP78(E!
MP'F&-R46O*#"$G]T&^-.<')M$,K[?:0]A#]"J(2^\4S"IBSY%3()N,U]76[L
MF" 02#@C!?BNQ;5QBZ:+J#DP9T[TF"X_$;2UAN<.%4;WH9.B\FQ$FXX,6-P<
M518<'UTUR[ Y!"<;R?BU/=4(P+IU08:"2VUB"I,,%9+>9Y_#M+L_/'Z\S:HT
M'$1\.:DJ?[GFZ(F]4SJ*$ZSQW,.%JC&&9TWA.I/HZ=9"C7N"5:(E/@3?U^#Z
M71$HZ6:O=QD\4%?+&CM==0%/E]H\+[XI2_\*<?K#U%(01<5%9F7)WN/D#K=W
M0"!H=/(Y>%GCTE1J]02I*A=R*'*BU:%F$KB5G),GQN/$[6C>LL0W@B(7-T%1
M_C<74)34TH 8^O)<WC3PD>XDV#0C/=,%3.8DZ=07?032*'NUJI%/=LIMW*P8
M(O*\5I<Y-60+B,*MZAXZ)E.'PT_TS28IN&Z(6:1NIZPLFY13.*K**!C)7KA&
M+_V48DP3,<!$;\GCP<BE2V/T+M,H7*11WVQUFBQA\H/;B6K'-(S:CB4W,ZLS
MUP_-Y F(W'B"^0\+.[R;&WDRN)'[@WJV-:BO<M=RPZ%MQ.DZ+JDG8!5\66K=
M:[A9:0.9?J+#9P<I>[FYX9<P#JS@QJV,T4=2^.AAL([3(CT!R6E\R4?DHUIU
M,#PPEE*V^ 4L[PT][U (SMZ?>[T'[A##BF)>P[@J5T?[XLZ^!1G%6F.)5TTE
M&1TGT+2,#[^1_(39,=QETL/]G9Q$@C$^[T0?*?ZKWQ.7E"G/)9  9^>U^\EI
MGIT)C_=GELS<DJTZ'=RJ?T:6)Z>F@M-7HV2[SWH,,ISI0SW.O" _"04Y=_V&
M*<[4=@SC@"9,[3K:2>FDEV_(1EPB&S",.[T',Q:&/G[P^#:N.'BE&U2^)\$Z
MD)E#2<TTEE_E./W$BOKMJB5DD$C!'V7.G'5(_'8SZ$SQ1DA@-1W$"B\L:58;
M!MXFZ*^J"&1D?<"B <X1H+N 79;D2\E732EIHI05P<L3/KI"FZLJAVM&3#<G
M";9600E85%) 50_RV3]6TY-%N &UD#$(% 66(A)FNA:_9/ BD56$"N$B!S>P
MWG'+) :U(_M39"I(@V.?[3Z"1_EM'07,=I*_*L^OVIOQT[F;@S[<QZEU&?*9
MG>/PUSZ0K&:Q<!1+K[B<$'6^T8^.=Y@_E-/_(2MHUZN/6XM-P8DOG<UT"#HI
MQ\F07D[?,J'[BPT=W\';-V]>'Q\?'M["B-:+36)OWY\B,YO:US?&URXU&BV%
MYR:<]Q9ZG#(]826-4!H^NL@V"09NU:!7,D)]DI=!V<H6_E 24P&5\M[NR^W!
M)N1J@+WH,$/X8%XF&C7(!WC$D)07$E2W8*SA6;6^\D9/+4R@.:2%;V'?GRQ3
M:^M.X"@>]_N9%YG#W)4D"E<I,C7[!,M$1XYV'.'PKJ#-NU634M3DUXU %QH;
MEDJKZ)PA<_NL6F%K .?]CETOU"4*BZ"S8SMAIUM[/CBF?3"03B6_2F"1 TL]
MUR/%AA9!JEX']HK/DMW&O,.+36+?I]YCI!K<(MR8JNZRSU]&%4>!9 =X^LOW
M3U_<1E[R*Z2M(A+,T(,VJ(M 9_FV(6UPC HYB>D*P*>3=)%=5.)?Q<9L(XZ,
MAB#P %)V!2;N4](GN.4]1N+;QDBX0X.K#(A5I69&#Z;ZHE B+77TT_,E_T0<
M<PUQ^K:9KI.]YXHV7>R1S<#$D_%2(U:. LL7/XP"M@;3EB.9@+C#VZ<AXQ='
M75TYE=E(/BDB/]KJY+@,3PG31=,@ T3&#]0V<((CH$QRLP+/'VYF;XQ\RBGN
MF("D@)A8.!EE^G&H?6$>'10T,?7#3@\G65HTE<_D^KRIK=0PZ1>T?MBB,9C1
M5"DH+(UG5 G"0;XIKX$6?7&L1)/<HJ90.&Q5BBMQ5[0IJ3&?PN[+0E.\W@6!
M"+\I PD;#L6-AF"JL/'**>>USOW5DD4*P)\]+35N(]SS"DG@XRN>,1A8KI?P
M=X@2-)R>)( C030TDUR!>'TXAX1/#!2"*KQAI(U<F"O<ZCT(+TYV#F15>,\R
MI$,;]KI'N?2/IYD.H0734X%!*]/!L%ETIZ1L.$.Y3[DGD9BN[1@#-!QJ;YI-
MN(FXDF9U"NXPT3'+2P'"C'-6)1@Y@'45T^9.+<)P[NEUJ?&60AL:4<Q%=>]E
MHRZQ8<I&(_O $ZW)3O'>)9,:4;45'N.-Z]WE*[J(OJ0TG<)Y(<\?* F?25P-
MY&'UXEO;0V!PL;/+N!B!.?-L9R]1%KA2ZO"CN(9?V9+U6UYKRI+HO,&[.*'L
MB:D5#X\+>.A6O@T7W8FX%/>-W\*$!EN)<KBAF[5M;!%J0 8'"$.I##2&CQ\^
MOQ!BE134IEN+=T;85HBK#E?U9)YR4Y,)]LO.89;;$)@H6W!+J:HD:.CHPDH^
MF+GFF@=<./"5I?RE\8\D20)F_)U82[*L9WS&G*58155Q7<8V*[*Y!,HD.\4L
MR; 8K%"CA;8+RSQ(.2X88[NZ<A'(@:I--/*I'+MZ@#7C8,-*C XLIBJ=:H!N
MEC']&!^.G/LR)GS0 B]Z5$-A9\VTPB:NL("6"]1%74O$@&O'52Q5-\.6/\G]
M0]S;R&NKS8\I/00<(FB'W+E97C?6C9'\H\/:&;WOXD^V6>N=4O2S=:;5A2TR
M,=1M^VKVJ'[5];'/Z9I*<J1*@(32-4%1N^M%6<B_XGZU:]M.LMKI%$C>2DJ]
M%YO4V/ 5G^Z>5>\&8]"'5V&-BV ,GCDNXHWKZQ $.J\BFS3EJ@$BNZAJR[(7
MY&L4D;7DH+U4$EB2/;E*,W[:!D1MJ.!!:=U>YBD&E;@^LD(;EBP)\J,EUQ,"
M:7SY$[GX@;/-4;P11@G57W#T)')RF+$$3#A">,C0-I,KS=N+!HWW@!-FLB);
MT[#XF>-@QW="D143\V7JA==A7TZKCSV<IQ;*?AL/DA>;U%'QM6'EX!*Y7U<U
M^)9S1G9M1**+^[UC[:T2&>3.PYGQ:#OYF';NRM53ACB;%^4^#[XNPDND!=*V
M@I,%G53C28>=#U=$'$(#J[,)40]&^,W..%-1/HZCP1,&U+T\ I9X:;!J?Y04
M&1&!S;"8 VE;\(@V5?V,-S-)9I<$!,L#=GF#>U@J":($O)\7@7[SB[)X4#P
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MB8=#Q7WRS"U%<(IUPF_99%53\D$OA#6$9S_H>_@+?C@EK^X$RZ*=!+^'=3I
M/L_@V.>UYT5LL:EKJQ.V]ZC[BU2:TU$4EX+AM/E 9>'41K_6^^QVM41'+ZQ5
M LF6.F:_O#Y^M2]'CXKXWI[3 ;- _X*TXR;AAI)L[[N KGO)QP/;&\;PE^^?
M/']YT3;? YFF_BS58NSYPZ7S!(;'N06EV1RC8>[H>]#554%77]6^[&L"P.*
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M];*+P6:QYG*D3O45F)%@Y:S16YL14'@XKJ;G\'_S=E'\_/\!4$L! A0#%
M  @ 6V.S5B/KLX<"&0  X>4  !$              ( !     &%O<G0M,C R
M,S U,3DN:'1M4$L! A0#%     @ 6V.S5LLY%O9H @  ;@<  !$
M     ( !,1D  &%O<G0M,C R,S U,3DN>'-D4$L! A0#%     @ 6V.S5E@'
M68%("@  &%T  !4              ( !R!L  &%O<G0M,C R,S U,3E?;&%B
M+GAM;%!+ 0(4 Q0    ( %MCLU:8X[TTI08  -PP   5              "
M 4,F  !A;W)T+3(P,C,P-3$Y7W!R92YX;6Q02P$"% ,4    " !;8[-6[+BI
MEP]%  "JO0$ '@              @ $;+0  97@Q,#$M,C R,&%R=&EV:6]N
B97%U:71Y86XN:'1M4$L%!@     %  4 4 $  &9R      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
